What is the market doing?
What the tape says about CGEM
Cullinan Therapeutics, Inc. is +225% over the past year while the S&P 500 is +23%: 202 points ahead of the market.
+225%
1-year return · S&P 500 +23%
- vs 200-day average
- +69%
vs 200-day average · a clear uptrend
- RSI (14)
- 80
RSI (14) · overbought, bought harder than it has been sold
- Below its 52-week high
- −0.63%
Below its 52-week high
Details›
- Last close2026-08-26
- $22.84
- 1 monthS&P 500 +3.7%
- +32%
- 1 yearS&P 500 +23%
- +225%
- 5 yearsS&P 500 +87%
- −5.5%
- vs 50-day average$17.43
- +31%
- 52-week high
- $22.98
- 52-week low
- $5.75
- Annualised volatility
- 69%
- Insider buying, net, 6 monthsForms 3/4/5 to 2026-06-30
- −$721K
| Year | Return |
|---|---|
| 2026 (year to date) | +121% |
| 2025 | −15% |
| 2024 | +20% |
| 2023 | −3.4% |
| 2022 | −32% |
| Month | Years | Positive | Average |
|---|---|---|---|
| Jan | 5 | 3 of 5 | +9.7% |
| Feb | 6 | 4 of 6 | +7.0% |
| Mar | 6 | 1 of 6 | −10% |
| Apr | 6 | 2 of 6 | +4.4% |
| May | 6 | 4 of 6 | +3.9% |
| Jun | 6 | 3 of 6 | −2.5% |
| Jul | 6 | 3 of 6 | +0.26% |
| Aug | 6 | 3 of 6 | +8.3% |
| Sep | 5 | 0 of 5 | −15% |
| Oct | 5 | 3 of 5 | +8.6% |
| Nov | 5 | 1 of 5 | −3.8% |
| Dec | 5 | 1 of 5 | −4.7% |
End-of-day closes from IEX; the S&P 500 comparison uses SPY over the same window. Prices are a reference point, not a basis for trading decisions.
Biotechnology
The closest names by size in the same industry